Astria Therapeutics
(ATXS)
|
10.3 |
$20M |
|
1.4M |
14.89 |
Adma Biologics
(ADMA)
|
5.7 |
$11M |
|
2.9M |
3.88 |
Chinook Therapeutics
|
5.1 |
$10M |
|
385k |
26.20 |
Bellus Health Com New
|
4.7 |
$9.3M |
|
1.1M |
8.22 |
Pepperlime Health Acqustn Class A Ord Shs
|
3.8 |
$7.5M |
|
735k |
10.21 |
Akero Therapeutics
(AKRO)
|
3.5 |
$6.9M |
|
125k |
54.80 |
Cymabay Therapeutics
|
3.3 |
$6.4M |
|
1.0M |
6.27 |
Verona Pharma Sponsored Ads
(VRNA)
|
2.9 |
$5.6M |
|
215k |
26.13 |
Intra Cellular Therapies
(ITCI)
|
2.7 |
$5.3M |
|
100k |
52.92 |
Amylyx Pharmaceuticals
(AMLX)
|
2.6 |
$5.2M |
|
140k |
36.95 |
Rhythm Pharmaceuticals
(RYTM)
|
2.5 |
$5.0M |
|
170k |
29.12 |
Arcellx Common Stock
(ACLX)
|
2.4 |
$4.6M |
|
150k |
30.98 |
Replimune Group
(REPL)
|
2.2 |
$4.4M |
|
160k |
27.20 |
Karuna Therapeutics Ord
|
2.2 |
$4.3M |
|
22k |
196.50 |
Xtant Med Hldgs Com New
(XTNT)
|
2.1 |
$4.1M |
|
6.2M |
0.66 |
Iveric Bio
|
2.1 |
$4.1M |
|
190k |
21.41 |
Tandem Diabetes Care Com New
(TNDM)
|
2.1 |
$4.0M |
|
90k |
44.95 |
Glaukos
(GKOS)
|
2.0 |
$4.0M |
|
91k |
43.68 |
Esperion Therapeutics
(ESPR)
|
2.0 |
$3.9M |
|
620k |
6.23 |
Outlook Therapeutics Com New
|
1.8 |
$3.6M |
|
3.3M |
1.08 |
ResMed
(RMD)
|
1.8 |
$3.5M |
|
17k |
208.13 |
Akoya Biosciences
(AKYA)
|
1.6 |
$3.2M |
|
330k |
9.57 |
Quanterix Ord
(QTRX)
|
1.6 |
$3.1M |
|
225k |
13.85 |
Myriad Genetics
(MYGN)
|
1.6 |
$3.1M |
|
212k |
14.51 |
Repro-Med Systems
(KRMD)
|
1.6 |
$3.1M |
|
855k |
3.57 |
Nevro
(NVRO)
|
1.5 |
$3.0M |
|
76k |
39.60 |
Pacific Biosciences of California
(PACB)
|
1.5 |
$3.0M |
|
365k |
8.18 |
Biohaven
(BHVN)
|
1.4 |
$2.8M |
|
200k |
13.88 |
Cti Biopharma
|
1.4 |
$2.7M |
|
450k |
6.01 |
Si-bone
(SIBN)
|
1.3 |
$2.7M |
|
195k |
13.60 |
Neogenomics Com New
(NEO)
|
1.3 |
$2.6M |
|
285k |
9.24 |
Cara Therapeutics
(CARA)
|
1.1 |
$2.1M |
|
196k |
10.74 |
Neurocrine Biosciences
(NBIX)
|
1.1 |
$2.1M |
|
18k |
119.44 |
Collegium Pharmaceutical Inc Common Stock Usd
(COLL)
|
1.1 |
$2.1M |
|
90k |
23.20 |
Vaxcyte
(PCVX)
|
1.0 |
$2.1M |
|
43k |
47.95 |
Tg Venture Acquisition Corp Unit 08/15/2028
|
1.0 |
$2.0M |
|
200k |
10.19 |
Pliant Therapeutics
(PLRX)
|
1.0 |
$1.9M |
|
100k |
19.33 |
Sage Therapeutics
(SAGE)
|
1.0 |
$1.9M |
|
50k |
38.14 |
Biolinerx Sponsored Ads
(BLRX)
|
0.9 |
$1.8M |
|
3.1M |
0.59 |
Ault Disruptive Techs Corp
(ADRT)
|
0.8 |
$1.5M |
|
150k |
10.25 |
Tg Therapeutics Call Call Option
|
0.6 |
$1.2M |
|
100k |
11.83 |
Syros Pharmaceuticals Com New
(SYRS)
|
0.6 |
$1.1M |
|
315k |
3.59 |
Western Acqstn Ventures Corp Unit 09/01/2026
(WAVSU)
|
0.6 |
$1.1M |
|
100k |
11.00 |
Murphy Canyon Acquisition Unit 01/25/2027
|
0.5 |
$1.0M |
|
100k |
10.18 |
Arya Sciences Acqu Corp Iv Cl A
(ARYD)
|
0.5 |
$1.0M |
|
100k |
10.10 |
Coliseum Acquisition Corp Class A Ord Shs
(MITA)
|
0.4 |
$853k |
|
85k |
10.04 |
Taysha Gene Therapies Com Shs
(TSHA)
|
0.4 |
$812k |
|
359k |
2.26 |
Somalogic Class A Com
|
0.4 |
$778k |
|
310k |
2.51 |
Hyrecar
(HYREQ)
|
0.4 |
$716k |
|
1.7M |
0.42 |
Terns Pharmaceuticals
(TERN)
|
0.4 |
$713k |
|
70k |
10.18 |
Fat Brands *w Exp 07/16/202
(FATBW)
|
0.3 |
$683k |
|
227k |
3.01 |
Rxsight
(RXST)
|
0.3 |
$641k |
|
51k |
12.67 |
1847 Goedeker
|
0.3 |
$578k |
|
1.0M |
0.58 |
Pepgen
(PEPG)
|
0.3 |
$535k |
|
40k |
13.37 |
Gsr Ii Meteora Acquisitn Cor Unit 02/24/2027
|
0.3 |
$529k |
|
50k |
10.57 |
Doubledown Interactive Co Lt Ads
(DDI)
|
0.3 |
$514k |
|
61k |
8.45 |
Opy Acquisition Corp I Com Cl A
|
0.3 |
$501k |
|
50k |
10.02 |
Colombier Acquisition Corp Cl A
|
0.3 |
$497k |
|
50k |
9.94 |
Polished *w Exp 06/02/202
(POLWQ)
|
0.2 |
$488k |
|
6.1M |
0.08 |
Mediwound Shs New
(MDWD)
|
0.2 |
$368k |
|
27k |
13.49 |
Kura Oncology
(KURA)
|
0.2 |
$350k |
|
28k |
12.41 |
Abeona Therapeutics Com New
(ABEO)
|
0.2 |
$335k |
|
109k |
3.08 |
Troika Media Group
|
0.2 |
$310k |
|
2.7M |
0.12 |
Lightning Emotors
|
0.1 |
$213k |
|
582k |
0.37 |
Wearable Devices *w Exp 09/14/202
(WLDSW)
|
0.1 |
$171k |
|
1.4M |
0.12 |
Direct Digital Holdings *w Exp 02/15/202
|
0.1 |
$140k |
|
180k |
0.78 |
Astria Therapeutics Call Call Option
|
0.1 |
$115k |
|
7.7k |
14.89 |
Health Sciences Acq Corp 2 Ord Shs
|
0.1 |
$100k |
|
10k |
9.98 |
Jeffs Brands *w Exp 08/26/202
(JFBRW)
|
0.0 |
$79k |
|
481k |
0.17 |
Cingulate *w Exp 12/10/202
(CINGW)
|
0.0 |
$65k |
|
270k |
0.24 |
Onfolio Holdings *w Exp 01/02/202
(ONFOW)
|
0.0 |
$48k |
|
200k |
0.24 |
Harbor Custom Development In *w Exp 10/07/202
(HCDZQ)
|
0.0 |
$39k |
|
650k |
0.06 |
Nocturne Acquisition Corp Right 12/26/2025
|
0.0 |
$39k |
|
500k |
0.08 |
Nls Pharmaceutics *w Exp 02/02/202
(NLSPW)
|
0.0 |
$38k |
|
200k |
0.19 |
Nexgel *w Exp 12/01/202
(NXGLW)
|
0.0 |
$34k |
|
225k |
0.15 |
Lightning Emotors *w Exp 05/18/202
(ZEVYW)
|
0.0 |
$25k |
|
652k |
0.04 |
Pepperlime Health Acqustn *w Exp 10/01/202
|
0.0 |
$24k |
|
368k |
0.07 |
Cea Industries *w Exp 02/11/202
(CEADW)
|
0.0 |
$23k |
|
250k |
0.09 |
Chavant Capital Acquisitn *w Exp 99/99/999
|
0.0 |
$22k |
|
150k |
0.14 |
Nexalin Technology *w Exp 09/15/202
(NXLIW)
|
0.0 |
$21k |
|
105k |
0.20 |
Tilray Brands Call Call Option
|
0.0 |
$20k |
|
7.6k |
2.69 |
Bruush Oral Care *w Exp 08/03/202
(BRSWF)
|
0.0 |
$20k |
|
361k |
0.05 |
Innovative Eyewear *w Exp 08/16/202
(LUCYW)
|
0.0 |
$18k |
|
150k |
0.12 |
Harbor Custom Development In *w Exp 05/09/202
(HCDWQ)
|
0.0 |
$17k |
|
600k |
0.03 |
Digital Health Acquisition C *w Exp 11/02/202
(DHACW)
|
0.0 |
$15k |
|
150k |
0.10 |
Prosomnus *w Exp 04/20/202
(OSPWQ)
|
0.0 |
$12k |
|
150k |
0.08 |
Selina Hospitality *w Exp 10/27/202
(SLNWF)
|
0.0 |
$8.1k |
|
101k |
0.08 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$7.4k |
|
133k |
0.06 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$7.0k |
|
82k |
0.09 |
Opy Acquisition Corp I *w Exp 09/22/202
|
0.0 |
$3.2k |
|
50k |
0.06 |
Relativity Acquisition Corp *w Exp 12/15/202
|
0.0 |
$3.0k |
|
100k |
0.03 |
Coliseum Acquisition Corp *w Exp 08/22/202
(MITAW)
|
0.0 |
$2.0k |
|
28k |
0.07 |
Tc Biopharm Holdings *w Exp 02/08/202
(TCBPW)
|
0.0 |
$1.7k |
|
19k |
0.09 |
Colombier Acquisition Corp *w Exp 99/99/999
|
0.0 |
$1.4k |
|
17k |
0.09 |